The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
AMH and AMH receptor defects in persistent Müllerian duct syndrome
Abstract
Anti-Müllerian hormone (AMH) produced by fetal Sertoli cells is responsible for regression of Müllerian ducts, the anlage for uterus and Fallopian tubes, during male sex differentiation. A member of the transforming growth factor-beta superfamily, AMH signals through two transmembrane receptors, type II which is specific and type I receptors, shared with the bone morphogenetic protein family. Mutations of the AMH and AMH receptor type II (AMHR-II) genes lead to persistence of the uterus and Fallopian tubes in males. Both conditions are transmitted according to a recessive autosomal pattern and are symptomatic only in males. Affected individuals are otherwise normally virilized, undergo normal male puberty; and may be fertile if testes, tightly attached to the Fallopian tubes, can be replaced in the scrotum. Approximately 85% of the cases are due, in similar proportions, to mutations of the AMH or AMHR-II gene. The genetic background does not influence the phenotype, the only difference is the level of circulating AMH which is normal for age in AMHR-II mutants and usually low or undetectable in AMH gene defects. This is due to lack of secretion, explained by the localization of the mutations in critical regions, based on the assumed 3D structure of the molecule. Similarly, lack of translocation to the surface membrane is responsible for the inactivity of AMHR-II molecules bearing mutations in the extracellular domain. In 15% of cases, the cause of the persistent Mullerian duct syndrome is unknown and could be related to complex malformations of the urogenital region, unrelated to AMH physiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Weenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M., Cheung, A., Ninfa, E. G., Frey, A. Z., Gash, D. J., Chow, E. P., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90783-x · Cited by 1,022
Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1
Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (1999) · Endocrinology · doi:10.1210/endo.140.12.7204 · Cited by 1,011
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
van Rooij, I. A. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 951
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
TGFβ Signaling: Receptors, Transducers, and Mad Proteins
Massagué, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81296-9 · Cited by 837
The Bone Morphogenetic Protein System In Mammalian Reproduction
Shimasaki, S., Moore, R. K., Otsuka, F., & Erickson, G. F. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0007 · Cited by 741
Signal transduction of bone morphogenetic protein receptors
Nohe, A. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.08.011 · Cited by 514
Targeted Mutagenesis of the Endogenous Mouse Mis Gene Promoter
Arango, N. A., Lovell-Badge, R., & Behringer, R. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81527-5 · Cited by 449
Requirement of Bmpr1a for Müllerian duct regression during male sexual development
Jamin, S. P., Arango, N. A., Mishina, Y., Hanks, M. C., & Behringer, R. R. (2002) · Nature Genetics · doi:10.1038/ng1003 · Cited by 399
Mishina, Y., Rey, R., Finegold, M. J., Matzuk, M. M., Josso, N., Cate, R. L., & Behringer, R. R. (1996) · Genes & Development · doi:10.1101/gad.10.20.2577 · Cited by 359
Self-citationBaarends, W. M., Helmond, M. J. L. V., Post, M., Schoot, P. J. C. M. V. D., Hoogerbrugge, J. W., Winter, J. P. D., Uilenbroek, J. T. J., Karels, B., Wilming, L. G., Meijers, J. H. C., et al. (1994) · Development · doi:10.1242/dev.120.1.189 · Cited by 290
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
di Clemente, N., Wilson, C., Faure, E., Boussin, L., Carmillo, P., Tizard, R., Picard, J. Y., Vigier, B., Josso, N., & Cate, R. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.8.7997230 · Cited by 287
Self-citationAnti-Müllerian hormone and its role in ovarian function
Gruijters, M. J. G., Visser, J. A., Durlinger, A. L. L., & Themmen, A. P. N. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.024 · Cited by 238
Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19
Cohen-Haguenauer, O., Picard, J. Y., Mattéi, M.-G., Serero, S., Van Cong, N., de Tand, M.-F., Guerrier, D., Hors-Cayla, M.-C., Josso, N., & Frézal, J. (1987) · Cytogenetic and Genome Research · doi:10.1159/000132332 · Cited by 203
Self-citationGiuili, G., Shen, W.-H., & Ingraham, H. A. (1997) · Development · doi:10.1242/dev.124.9.1799 · Cited by 198
Clarke, T. R. (2001) · Molecular Endocrinology · doi:10.1210/me.15.6.946 · Cited by 171
Gouédard, L., Chen, Y.-G., Thevenet, L., Racine, C., Borie, S., Lamarre, I., Josso, N., Massagué, J., & di Clemente, N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002704200 · Cited by 163
Self-citationThe Serine/Threonine Transmembrane Receptor ALK2 Mediates Mullerian Inhibiting Substance Signaling
Visser, J. A. (2001) · Molecular Endocrinology · doi:10.1210/me.15.6.936 · Cited by 159
Imbeaud, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.9.1269 · Cited by 158
Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-β family
Josso, N., & di Clemente, N. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00005-5 · Cited by 137
Self-citationThe Persistent Mullerian Duct Syndrome: A Molecular Approach*
Guerrier, D., Tran, D., VANDERWINDEN, J. M., et al. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-46 · Cited by 133
di Clemente, N., Goxe, B., Rémy, J., Cate, R. L., Josso, N., Vigier, B., & Salesse, R. (1994) · HAL · Cited by 132
Self-citationEndometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance
Renaud, E., MacLaughlin, D. T., Oliva, E., Rueda, B. R., & Donahoe, P. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407772101 · Cited by 98
Belville, C., van Vlijmen, H., Ehrenfels, C. W., Pepinsky, B., Rezaie, A. R., Picard, J., Josso, N., di Clemente, N., & Cate, R. L. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0358 · Cited by 97
Self-citationMullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells
Hoshiya, Y., Gupta, V., Segev, D. L., Hoshiya, M., Carey, J., Sasur, L. M., Tran, T. T., Ha, T. U., & Maheswaran, S. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.010 · Cited by 77
Richter-Unruh, A., Verhoef‐Post, M., Malak, S., Homoki, J., Hauffa, B. P., & Themmen, A. P. N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0298 · Cited by 41
Cited by
Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care
Lee, P. A., Nordenström, A., Houk, C. P., Ahmed, S. F., Auchus, R., Baratz, A., Baratz Dalke, K., Liao, L.-M., Lin-Su, K., Looijenga 3rd, L. H. J., et al. (2016) · Hormone Research in Paediatrics · doi:10.1159/000442975 · Cited by 1,273
Contextual determinants of TGFβ action in development, immunity and cancer
David, C. J., & Massagué, J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0007-0 · Cited by 851
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications
Broer, S. L., Broekmans, F. J. M., Laven, J. S. E., & Fauser, B. C. J. M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu020 · Cited by 683
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Epigenetic modification and inheritance in sexual reversal of fish
Shao, C., Li, Q., Chen, S., Zhang, P., Lian, J., Hu, Q., Sun, B., Jin, L., Liu, S., Wang, Z., et al. (2014) · Genome Research · doi:10.1101/gr.162172.113 · Cited by 431
Metadata
- Authors
- Josso, N., Belville, C., di Clemente, N., & Picard, J.-Y.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-05
- Volume
- 11
- Issue
- 4
- Pages
- 351-356
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2122511354
- Cited by
- 307
- References
- 28
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.